[1] US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma,Retrieved January 21, 2020, from https://www.prnewswire.com/news-release.....
编译:菜菜_AM@微博/作者:世界卫生组织(WHO)来源:肿瘤资讯1月20日,世界卫生组织(WHO)出了一份"Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms .......